Port R - Search Results

1

Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging.

Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Brix G, et al. Among authors: port r. J Comput Assist Tomogr. 1991 Jul-Aug;15(4):621-8. doi: 10.1097/00004728-199107000-00018. J Comput Assist Tomogr. 1991. PMID: 2061479

2

Kinetic modeling of in vivo--nuclear magnetic resonance spectroscopy data: 5-fluorouracil in liver and liver tumors.

Port RE, Bachert P, Semmler W. Port RE, et al. Clin Pharmacol Ther. 1991 May;49(5):497-505. doi: 10.1038/clpt.1991.60. Clin Pharmacol Ther. 1991. PMID: 1903099

3

Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imaging.

Port RE, Knopp MV, Hoffmann U, Milker-Zabel S, Brix G. Port RE, et al. J Magn Reson Imaging. 1999 Sep;10(3):233-41. doi: 10.1002/(sici)1522-2586(199909)10:3<233::aid-jmri3>3.0.co;2-m. J Magn Reson Imaging. 1999. PMID: 10508282

4

Dynamic contrast-enhanced MRI using Gd-DTPA: interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors.

Port RE, Knopp MV, Brix G. Port RE, et al. Magn Reson Med. 2001 Jun;45(6):1030-8. doi: 10.1002/mrm.1137. Magn Reson Med. 2001. PMID: 11378881 Free article.

5

Pharmacokinetic analysis of 5-[18F]fluorouracil tissue concentrations measured with positron emission tomography in patients with liver metastases from colorectal adenocarcinoma.

Kissel J, Brix G, Bellemann ME, Strauss LG, Dimitrakopoulou-Strauss A, Port R, Haberkorn U, Lorenz WJ. Kissel J, et al. Among authors: port r. Cancer Res. 1997 Aug 15;57(16):3415-23. Cancer Res. 1997. PMID: 9270007

6

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM. Tofts PS, et al. Among authors: port re. J Magn Reson Imaging. 1999 Sep;10(3):223-32. doi: 10.1002/(sici)1522-2586(199909)10:3<223::aid-jmri2>3.0.co;2-s. J Magn Reson Imaging. 1999. PMID: 10508281 Review.

7

Noninvasive determination of the arterial input function of an anticancer drug from dynamic PET scans using the population approach.

Kissel J, Port RE, Zaers J, Bellemann ME, Strauss LG, Haberkorn U, Brix G. Kissel J, et al. Among authors: port re. Med Phys. 1999 Apr;26(4):609-15. doi: 10.1118/1.598560. Med Phys. 1999. PMID: 10227363

8

Pharmacokinetic analysis of sparse in vivo NMR spectroscopy data using relative parameters and the population approach.

Port RE, Schlemmer HP, Bachert P. Port RE, et al. Eur J Clin Pharmacol. 1994;47(2):187-93. doi: 10.1007/BF00194971. Eur J Clin Pharmacol. 1994. PMID: 7859808

9

Simultaneous sustained release of fludarabine monophosphate and Gd-DTPA from an interstitial liposome depot in rats: potential for indirect monitoring of drug release by magnetic resonance imaging.

Port RE, Schuster C, Port CR, Bachert P. Port RE, et al. Among authors: port cr. Cancer Chemother Pharmacol. 2006 Nov;58(5):607-17. doi: 10.1007/s00280-006-0208-7. Epub 2006 Feb 28. Cancer Chemother Pharmacol. 2006. PMID: 16506037

10

Contrast-enhanced MR imaging in the indirect monitoring of drug release from an interstitial depot.

Port RE, Schuster C, Port CR, Bachert P. Port RE, et al. Among authors: port cr. Int J Clin Pharmacol Ther. 2005 Dec;43(12):605-6. doi: 10.5414/cpp43605. Int J Clin Pharmacol Ther. 2005. PMID: 16372536 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters